Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for LIVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 27.80%
March 31, 2026 6.15%
December 31, 2025 8.56%
September 30, 2025 7.49%
June 30, 2025 7.70%
March 31, 2025 -103.3%
December 31, 2024 17.37%
September 30, 2024 10.36%
June 30, 2024 5.13%
March 31, 2024 -14.41%
December 31, 2023 5.25%
September 30, 2023 -2.56%
June 30, 2023 0.39%
March 31, 2023 2.80%
December 31, 2022 0.61%
September 30, 2022 -42.49%
June 30, 2022 6.47%
March 31, 2022 1.25%
December 31, 2021 -1.90%
September 30, 2021 -17.16%
June 30, 2021 -21.36%
March 31, 2021 -12.42%
December 31, 2020 -104.1%
September 30, 2020 -6.15%
June 30, 2020 -48.29%
Date Value
March 31, 2020 15.92%
December 31, 2019 -49.86%
September 30, 2019 11.96%
June 30, 2019 -10.60%
March 31, 2019 -5.92%
December 31, 2018 -70.56%
September 30, 2018 -2.31%
June 30, 2018 6.79%
March 31, 2018 7.12%
December 31, 2017 -11.30%
September 30, 2017 10.75%
June 30, 2017 17.85%
March 31, 2017 5.83%
December 31, 2016 -9.59%
September 30, 2016 -0.53%
June 30, 2016 2.79%
March 31, 2016 -14.07%
January 31, 2015 22.95%
October 31, 2014 23.53%
July 31, 2014 18.78%
April 30, 2014 24.62%
January 31, 2014 20.38%
October 31, 2013 19.81%
July 31, 2013 12.59%
April 30, 2013 16.87%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
NovoCure Ltd. -8.53%
EKF Diagnostics Holdings Plc --
Niox Group Plc --
Polarean Imaging Plc --
Medtronic Plc 12.84%